Advertisement
Singapore markets closed
  • Straits Times Index

    3,300.04
    -3.15 (-0.10%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • Dow

    38,852.27
    +176.59 (+0.46%)
     
  • Nasdaq

    16,349.25
    +192.92 (+1.19%)
     
  • Bitcoin USD

    64,117.78
    -1,025.44 (-1.57%)
     
  • CMC Crypto 200

    1,331.79
    -33.34 (-2.44%)
     
  • FTSE 100

    8,289.99
    +76.50 (+0.93%)
     
  • Gold

    2,322.30
    -8.90 (-0.38%)
     
  • Crude Oil

    78.43
    -0.05 (-0.06%)
     
  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     
  • Nikkei

    38,835.10
    +599.03 (+1.57%)
     
  • Hang Seng

    18,479.37
    -98.93 (-0.53%)
     
  • FTSE Bursa Malaysia

    1,605.68
    +8.29 (+0.52%)
     
  • Jakarta Composite Index

    7,123.61
    -12.28 (-0.17%)
     
  • PSE Index

    6,618.58
    -33.91 (-0.51%)
     

What Does NovoCure’s Valuation Trend Indicate?

What Does NovoCure’s Valuation Trend Indicate?

NovoCure’s (NVCR) net financial expenses increased from $2.18 million in the second quarter of 2017 to $2.86 million in the second quarter. NovoCure’s income tax expenses also increased from $3.46 million in the second quarter of 2017 to $5.56 million in the second quarter.